A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors

NCT04921878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.